Literature DB >> 2115588

Synthesis and central nervous system actions of thyrotropin-releasing hormone analogues containing a dihydroorotic acid moiety.

M Suzuki1, H Sugano, K Matsumoto, M Yamamura, R Ishida.   

Abstract

A series of thyrotropin-releasing hormone (TRH) analogues in which the pyroglutamic acid residue was replaced by (S)-4,5-dihydroorotic acid (Dio-OH) and the related derivatives were prepared. Their central nervous system actions based on spontaneous locomotor activity, antagonistic effect on reserpine-induced hypothermia, and antagonistic effect on pentobarbital anesthesia were evaluated and the structure-activity relationships are discussed. Of these, (1-methyl-(S)-4,5-dihydroorotyl)-L-histidyl-L-prolinamide (14b) showed the most potent activities, which were 30-90 times greater than those of TRH. Moreover, the thyrotropin-releasing activity of 14b was about 50 times weaker than that of TRH, and compound 14b (TA-0910) was selected as a potent candidate.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2115588     DOI: 10.1021/jm00170a014

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems.

Authors:  M Tanabe; Y Tokuda; K Takasu; K Ono; M Honda; H Ono
Journal:  Br J Pharmacol       Date:  2007-01-15       Impact factor: 8.739

2.  RNASeq-derived transcriptome comparisons reveal neuromodulatory deficiency in the CO₂ insensitive brown Norway rat.

Authors:  Madeleine M Puissant; Ashley E Echert; Chun Yang; Gary C Mouradian; Tyler Novotny; Pengyuan Liu; Mingyu Liang; Matthew R Hodges
Journal:  J Physiol       Date:  2014-12-08       Impact factor: 5.182

3.  Discovery of a low affinity thyrotropin-releasing hormone (TRH)-like peptide that exhibits potent inhibition of scopolamine-induced memory impairment in mice.

Authors:  Chhuttan L Meena; Shubdha Ingole; Satyendra Rajpoot; Avinash Thakur; Prajwal P Nandeker; Abhay T Sangamwar; Shyam S Sharma; Rahul Jain
Journal:  RSC Adv       Date:  2015-06-23       Impact factor: 3.361

4.  The role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases.

Authors:  Caitlin M Daimon; Patrick Chirdon; Stuart Maudsley; Bronwen Martin
Journal:  Am J Alzheimers Dis (Columbia)       Date:  2013

5.  Thyrotropin-releasing hormone receptor type 1 (TRH-R1), not TRH-R2, primarily mediates taltirelin actions in the CNS of mice.

Authors:  Nanthakumar Thirunarayanan; Eshel A Nir; Bruce M Raaka; Marvin C Gershengorn
Journal:  Neuropsychopharmacology       Date:  2012-12-11       Impact factor: 7.853

6.  An amygdala circuit that suppresses social engagement.

Authors:  Changhyeon Ryu; Hyeseung Lee; Jeong-Tae Kwon; Alec Sheffield; Jingxuan Fan; Daniel H Cho; Shivani Bigler; Heather A Sullivan; Han Kyung Choe; Ian R Wickersham; Myriam Heiman; Gloria B Choi
Journal:  Nature       Date:  2021-03-31       Impact factor: 69.504

Review 7.  The Thyrotropin-Releasing Hormone-Degrading Ectoenzyme, a Therapeutic Target?

Authors:  Jean-Louis Charli; Adair Rodríguez-Rodríguez; Karina Hernández-Ortega; Antonieta Cote-Vélez; Rosa María Uribe; Lorraine Jaimes-Hoy; Patricia Joseph-Bravo
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

8.  Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{N-[(4S,5S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)-l-alanyl}-(2R)-2-methylpyrrolidine Trihydrate (Rovatirelin Hydrate).

Authors:  Naotake Kobayashi; Norihito Sato; Yuko Fujimura; Tsuyoshi Kihara; Katsuji Sugita; Kouji Takahashi; Katsumi Koike; Tamio Sugawara; Yukio Tada; Hiroshi Nakai; Takayoshi Yoshikawa
Journal:  ACS Omega       Date:  2018-10-19

9.  Taltirelin is a superagonist at the human thyrotropin-releasing hormone receptor.

Authors:  Nanthakumar Thirunarayanan; Bruce M Raaka; Marvin C Gershengorn
Journal:  Front Endocrinol (Lausanne)       Date:  2012-10-09       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.